No abstract available
Keywords:
Checkpoint inhibitors; immunotherapy; nivolumab; renal cell carcinoma; targeted therapy.
MeSH terms
-
Humans
-
Immunotherapy / methods*
-
Melanoma / pathology
-
Melanoma / therapy*
-
Risk Factors
-
Skin Neoplasms / pathology
-
Skin Neoplasms / therapy*